Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.

Détails

ID Serval
serval:BIB_4C1E52575884
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.
Périodique
Proceedings of the National Academy of Sciences of the United States of America
Auteur⸱e⸱s
Hailfinger S., Nogai H., Pelzer C., Jaworski M., Cabalzar K., Charton J.E., Guzzardi M., Décaillet C., Grau M., Dörken B., Lenz P., Lenz G., Thome M.
ISSN
1091-6490 (Electronic)
ISSN-L
0027-8424
Statut éditorial
Publié
Date de publication
2011
Volume
108
Numéro
35
Pages
14596-14601
Langue
anglais
Résumé
The protease activity of the paracaspase Malt1 contributes to antigen receptor-mediated lymphocyte activation and lymphomagenesis. Malt1 activity is required for optimal NF-κB activation, but little is known about the responsible substrate(s). Here we report that Malt1 cleaved the NF-κB family member RelB after Arg-85. RelB cleavage induced its proteasomal degradation and specifically controlled DNA binding of RelA- or c-Rel-containing NF-κB complexes. Overexpression of RelB inhibited expression of canonical NF-κB target genes and led to impaired survival of diffuse large B-cell lymphoma cell lines characterized by constitutive Malt1 activity. These findings identify a central role for Malt1-dependent RelB cleavage in canonical NF-κB activation and thereby provide a rationale for the targeting of Malt1 in immunomodulation and cancer treatment.
Mots-clé
Caspases/physiology, Cell Line, Tumor, Humans, Lymphocyte Activation, Lymphocytes/metabolism, Lymphoma, Large B-Cell, Diffuse/etiology, Lymphoma, Large B-Cell, Diffuse/metabolism, NF-kappa B/metabolism, Neoplasm Proteins/physiology, Transcription Factor RelA/metabolism, Transcription Factor RelB/metabolism
Pubmed
Web of science
Open Access
Oui
Création de la notice
26/10/2011 12:29
Dernière modification de la notice
20/08/2019 14:00
Données d'usage